Skip to main content

Advertisement

Table 3 Linear regression models to predict DAS28 and HAQ score at the fifth year of follow-up

From: Window of opportunity to achieve major outcomes in early rheumatoid arthritis patients: how persistence with therapy matters

Variablesa DAS28 at the fifth yearb HAQ at the fifth yearc
Male sex 0.64, (0.005 to 1.28), 0.05  
Baseline DAS28 0.24, (0.09 to 0.38), 0.002  
Months of persistence duration during the first 4 years −0.28, (−0.045 to −0.011), 0.002 −0.12, (−0.019 to −0.005), 0.001
Age   0.10, (0.004 to 0.016), 0.001
  1. DAS28 Disease Activity Score in 28 joints, HAQ Health Assessment Questionnaire
  2. aData are presented as β coefficients (95 % confidence interval), p value
  3. b R 2 = 0.338
  4. c R 2 = 0.281